Study: Supplies of a Drug Meant to Fight Opioid Addiction Fell During the Pandemic


Researchers say regulations that limit patient access to methadone may have contributed to a significant decline in supplies of the opioid use disorder medication within the U.S. since the beginning of the pandemic.

The nation’s supply of methadone per capita fell 20% in the second quarter of 2020 compared to the first quarter of that year, marking the biggest decrease over the last decade, according to the findings of an analysis published Tuesday in JAMA Network Open.